HEXO Corp. Cash and Cash Equivalents 2011-2026 | HEXO

Annual Cash and Cash Equivalents HEXO Corp.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
83.2 M	67.5 M	184 M	114 M	99 M	38.5 M	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
184 M	38.5 M	97.7 M

Quarterly Cash and Cash Equivalents HEXO Corp.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	67.5 M	-	-	-	184 M	-	-	-	114 M	-	-	-	99 M	-	-	-	38.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
184 M	38.5 M	101 M

Cash and Cash Equivalents of other stocks in the Drug manufacturers industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
Aurora Cannabis ACB	138 M	$ 3.53	2.17 %	$ 86.3 M	Canada
Alimera Sciences ALIM	12.1 M	-	-	$ 142 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.08 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	37.2 M	-	-	$ 754 M	USA
AcelRx Pharmaceuticals ACRX	8.86 M	-	7.5 %	$ 6.35 M	USA
Canopy Growth Corporation CGC	114 M	$ 1.06	3.92 %	$ 114 M	Canada
Agile Therapeutics AGRX	2.56 M	-	10.11 %	$ 58.2 M	USA
Assertio Holdings ASRT	10.2 M	$ 12.09	2.72 %	$ 77.4 M	USA
DURECT Corporation DRRX	28.4 M	-	-	$ 50.1 M	USA
Avadel Pharmaceuticals plc AVDL	51.4 M	-	-	$ 2.06 B	France
Eagle Pharmaceuticals EGRX	55.3 M	-	-39.89 %	$ 27.7 M	USA
Evolus EOLS	53.8 M	$ 4.77	-5.36 %	$ 308 M	USA
Evoke Pharma EVOK	4.74 M	-	-	$ 36.6 M	USA
Calliditas Therapeutics AB (publ) CALT	956 M	-	-0.1 %	$ 2.03 B	Schweden
Catalent CTLT	289 M	-	-	$ 11.5 B	USA
Cumberland Pharmaceuticals CPIX	18 M	$ 3.01	-1.63 %	$ 42.3 M	USA
Jupiter Wellness JUPW	349 K	-	-	$ 33.6 M	USA
Athenex ATNX	30.4 M	-	-23.39 %	$ 1.76 M	USA
Endo International plc ENDP	778 M	-	-	$ 28.9 M	Irlanda
Harrow Health HROW	72.9 M	$ 35.11	0.57 %	$ 1.29 B	USA
Organogenesis Holdings ORGO	136 M	$ 2.56	-0.97 %	$ 337 M	USA
Emergent BioSolutions EBS	112 M	$ 8.13	-2.4 %	$ 416 M	USA
OrganiGram Holdings OGI	24.6 M	$ 1.44	1.56 %	$ 402 M	Canada
Pacira BioSciences PCRX	277 M	$ 21.79	-3.99 %	$ 1.01 B	USA
China Pharma Holdings CPHI	600 K	$ 0.61	-2.26 %	$ 10.7 M	China
Sundial Growers SNDL	218 M	$ 1.45	0.35 %	$ 3.37 M	Canada
Veru VERU	24.9 M	$ 2.44	2.74 %	$ 329 M	USA
ProPhase Labs PRPH	9.11 M	-	-	$ 5.07 M	USA
TherapeuticsMD TXMD	4.33 M	$ 2.3	5.99 %	$ 24 M	USA
Lannett Company LCI	87.9 M	-	1.15 %	$ 7.11 M	USA
Radius Health RDUS	112 M	-	-	$ 1.42 B	USA
Viatris VTRS	992 M	$ 13.84	2.43 %	$ 16.6 B	USA
Perrigo Company plc PRGO	532 M	$ 10.44	7.36 %	$ 1.45 B	USA
Neoleukin Therapeutics NLTX	148 M	-	-	$ 193 M	Canada
Sonoma Pharmaceuticals SNOA	5.37 M	$ 2.45	1.66 %	$ 3.04 M	USA
Relmada Therapeutics RLMD	4.09 M	$ 6.39	3.4 %	$ 192 M	USA
Rockwell Medical RMTI	8.98 M	$ 1.05	9.39 %	$ 24.5 M	USA
PetIQ PETQ	116 M	-	1.64 %	$ 400 M	USA
OptiNose OPTN	73.7 M	-	-	$ 1.08 B	USA
PLx Pharma PLXP	69.4 M	-	-27.8 %	$ 2.56 M	USA
SCYNEXIS SCYX	21.3 M	$ 0.92	2.01 %	$ 45.9 M	USA
Recro Pharma REPH	8.1 M	-	-4.76 %	$ 65.3 M	USA
Solid Biosciences SLDB	80.2 M	$ 7.8	4.28 %	$ 318 M	USA
Tilray TLRY	207 M	$ 6.96	0.87 %	$ 4.3 B	Canada
Tricida TCDA	21.1 M	-	-	$ 3.25 M	USA
cbdMD YCBD	2.45 M	$ 0.75	4.19 %	$ 3.23 M	USA
Zynerba Pharmaceuticals ZYNE	50.6 M	-	-	$ 55.5 M	USA
Zomedica Corp. ZOM	9.02 M	-	-0.21 %	$ 98 M	USA